Filing Details
- Accession Number:
- 0001593968-22-000613
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-03 16:06:20
- Reporting Period:
- 2022-03-01
- Accepted Time:
- 2022-03-03 16:06:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1626325 | Mark Jonathan Hopper | C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-01 | 10,000 | $10.95 | 55,914 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-01 | 10,000 | $41.41 | 45,914 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-01 | 10,000 | $18.00 | 55,914 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-03-01 | 6,738 | $41.46 | 49,176 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-03-01 | 10,000 | $0.00 | 10,000 | $10.95 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-03-01 | 10,000 | $0.00 | 10,000 | $18.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 37,604 | 2028-08-20 | No | 4 | M | Direct | |
| 38,750 | 2030-02-11 | No | 4 | M | Direct |
Footnotes
- These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.
- These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
- These options, representing the right to purchase 48,750 shares, became exercisable in quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 11, 2020.
Billionaire Hedge Funds
